Journal article

In vitro susceptibility of recent Chlamydia trachomatis clinical isolates to the CtHtrA inhibitor JO146

Vanissa A Ong, Amba Lawrence, Peter Timms, Lenka A Vodstrcil, Sepehr N Tabrizi, Kenneth W Beagley, John A Allan, Jane S Hocking, Wilhelmina M Huston

Microbes and Infection | ELSEVIER | Published : 2015

Grants

Awarded by NHMRC Project


Awarded by ARC Linkage Project from The Wesley and Saint Andrews Research Institute


Funding Acknowledgements

The project that collected the clinical isolates that were used in this study was funded by NHMRC Project Grant (APP1023239). The work conducted here to analyse the impact of JO146 on these clinical isolates was funded by ARC Linkage Project LP1102500077 which includes partner funding from The Wesley and Saint Andrews Research Institute. Professor Matt Bogyo (Stanford University) and Dr Joel Tyndall (University of Otago) contributed to the identification of JO146. We wish to thank the ACTS study nurses Ruthy McIver and Karen Worthington, and also acknowledge Marcus Chen, Christopher K Fairley and Anna McNulty for facilitating recruitment in their clinics.